Belite Bio, Inc Cash and Restricted Cash
Belite Bio, Inc (BLTE) had Cash and Restricted Cash of $352.93 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-31
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $352.93M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.68M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $88.16M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42.09M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $352.93M 20-F · filed 2026-03-31 |
| 2024-12-31 | $31.68M 20-F · filed 2026-03-31 |
| 2023-12-31 | $88.16M 20-F · filed 2026-03-31 |
| 2022-12-31 | $42.09M 20-F · filed 2026-03-31 |
| 2021-12-31 | $17.34M 20-F · filed 2025-03-17 |
| 2020-12-31 | $25.62M 20-F · filed 2024-03-12 |
| 2019-12-31 | $2.02M 20-F · filed 2023-03-31 |